Capricor Therapeutics (CAPR) EBT Margin Growth (3y) (2014 - 2024)
Capricor Therapeutics (CAPR) EBT Margin Growth (3y) (2014 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
220,557.00 |
| Mar 31, 2024 |
1.25 Mn |
| Dec 31, 2023 |
721,765.00 |
| Sep 30, 2023 |
2.31 Mn |
| Jun 30, 2023 |
679,927.00 |
| Mar 31, 2023 |
86,263.00 |
| Dec 31, 2022 |
-13,917.00 |
| Sep 30, 2022 |
73,054.00 |
| Jun 30, 2021 |
-146,176.00 |
| Mar 31, 2021 |
-1.17 Mn |
| Dec 31, 2020 |
-652,065.00 |
| Sep 30, 2020 |
-2.23 Mn |
| Jun 30, 2020 |
-587,754.00 |
| Mar 31, 2020 |
-70,644.00 |
| Dec 31, 2019 |
-45,933.00 |
| Sep 30, 2019 |
730,997.00 |
| Jun 30, 2019 |
1,639.00 |
| Mar 31, 2019 |
-62,489.00 |
| Dec 31, 2018 |
-37,688.00 |
| Sep 30, 2018 |
-166,504.00 |
